PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.21%
Revenue growth similar to IXX.DE's 18.00%. Walter Schloss would see if both companies share industry tailwinds.
-55.14%
Negative gross profit growth while IXX.DE is at 51.93%. Joel Greenblatt would examine cost competitiveness or demand decline.
17.70%
EBIT growth below 50% of IXX.DE's 506.76%. Michael Burry would suspect deeper competitive or cost structure issues.
56.40%
Operating income growth under 50% of IXX.DE's 443.59%. Michael Burry would be concerned about deeper cost or sales issues.
19.91%
Net income growth under 50% of IXX.DE's 532.91%. Michael Burry would suspect the firm is falling well behind a key competitor.
18.42%
EPS growth under 50% of IXX.DE's 542.86%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
18.42%
Diluted EPS growth under 50% of IXX.DE's 542.86%. Michael Burry would worry about an eroding competitive position or excessive dilution.
1.20%
Slight or no buybacks while IXX.DE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.20%
Slight or no buyback while IXX.DE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
18.14%
Dividend growth of 18.14% while IXX.DE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-57.95%
Negative OCF growth while IXX.DE is at 210.41%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-69.63%
Negative FCF growth while IXX.DE is at 402.53%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
65.64%
10Y revenue/share CAGR under 50% of IXX.DE's 190.98%. Michael Burry would suspect a lasting competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
0.73%
3Y revenue/share CAGR under 50% of IXX.DE's 85.85%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
90.43%
Below 50% of IXX.DE's 184.74%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-18.30%
Negative 3Y CAGR while IXX.DE is 629.71%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
128.08%
Equity/share CAGR of 128.08% while IXX.DE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
No Data
No Data available this quarter, please select a different quarter.
93.54%
3Y equity/share CAGR above 1.5x IXX.DE's 12.60%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.14%
AR growth well above IXX.DE's 15.14%. Michael Burry fears inflated revenue or higher default risk in the near future.
25.89%
Inventory growth well above IXX.DE's 8.14%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
25.70%
Asset growth above 1.5x IXX.DE's 10.21%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.10%
We have a declining book value while IXX.DE shows 3.36%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
91.53%
Debt growth far above IXX.DE's 9.47%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-51.43%
We cut SG&A while IXX.DE invests at 4.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.